Mechanism of action
Calcium chloride dissociates in solution to provide ionized calcium (Ca²⁺), which is the physiologically active form. Calcium is essential for numerous cellular processes including neuromuscular transmission, muscle contraction, cardiac automaticity, and blood coagulation.
In the cardiovascular system, calcium plays a critical role in cardiac excitation-contraction coupling and stabilization of cell membranes. When administered intravenously, calcium chloride rapidly increases serum ionized calcium concentrations.
Electrophysiologic effects include:
- Stabilization of myocardial membranes by raising the threshold potential
- Enhanced cardiac contractility through increased calcium availability for myocardial contraction
- Antagonism of hyperkalemia by counteracting potassium's effect on membrane excitability without lowering serum potassium
- Reversal of calcium channel blocker toxicity by overcoming competitive blockade at L-type calcium channels
Calcium chloride contains approximately 27% elemental calcium by weight (272 mg elemental calcium per gram), compared to calcium gluconate which contains only 9% elemental calcium. This three-fold difference makes calcium chloride more effective for rapid correction of severe hypocalcemia and emergency situations.
- Calcium chloride provides 3× more elemental calcium than calcium gluconate (27% vs 9%)
- Preferred over gluconate in cardiac arrest, severe hypocalcemia, and calcium channel blocker toxicity
- Must be given via central line when possible due to severe tissue necrosis risk with extravasation
- Contraindicated with concurrent digitalis therapy due to risk of fatal arrhythmias
- Stabilizes cardiac membranes in hyperkalemia without lowering serum potassium
- Dissociates directly in blood without requiring hepatic metabolism
- Ceftriaxone contraindication applies only to neonates (≤28 days); safe with line flushing in older patients
- Chvostek sign (facial twitch) and Trousseau sign (carpopedal spasm) indicate severe hypocalcemia requiring urgent treatment
Indications
Calcium chloride is indicated for acute, life-threatening conditions requiring rapid calcium repletion:
Emergency indications
- Acute symptomatic hypocalcemia: tetany, seizures, laryngospasm, prolonged QT interval
- Cardiac arrest: particularly in the setting of hyperkalemia, hypocalcemia, or calcium channel blocker toxicity
- Severe hyperkalemia: as a temporizing cardioprotective measure to stabilize membranes
- Calcium channel blocker overdose: to overcome receptor blockade and restore cardiac function
- Magnesium sulfate toxicity: to reverse respiratory depression and cardiac effects
Perioperative and critical care uses
- Massive transfusion protocols to prevent citrate-induced hypocalcemia
- Treatment of hypocalcemia during cardiopulmonary bypass
- Reversal of neuromuscular blockade in combination with other agents
- Management of hydrofluoric acid burns (topical and intravenous)
Special situations
- Beta-blocker toxicity refractory to other therapies
- Prophylaxis before rapid blood transfusion in patients at risk for citrate toxicity
Calcium chloride is preferred over calcium gluconate in cardiac arrest and critically ill patients because it provides more elemental calcium and acts immediately upon dissociation in the blood.
Pharmacokinetics
Route of administration: Calcium chloride is given intravenously only. It must never be given intramuscularly or subcutaneously due to severe tissue damage.
Onset and duration:
- Onset of action is immediate following IV administration
- Peak effect occurs within minutes
- Duration depends on the underlying pathology and ongoing calcium losses
Distribution: Ionized calcium distributes throughout extracellular fluid. Approximately 40-45% of total serum calcium is protein-bound (primarily to albumin), 10-15% is complexed with anions (phosphate, citrate), and 45-50% exists as physiologically active ionized calcium.
Metabolism and excretion: Calcium is not metabolized. Homeostasis is maintained through a complex interplay of parathyroid hormone, vitamin D, and calcitonin, which regulate intestinal absorption, renal excretion, and bone resorption. Excess calcium is primarily excreted by the kidneys.
Special considerations:
- Calcium chloride dissociates directly in the blood to release ionized calcium without requiring hepatic metabolism
- The 10% solution provides 100 mg/mL of calcium chloride salt (27.2 mg/mL elemental calcium)
Adverse effects
Serious adverse effects
- Tissue necrosis: severe local tissue damage, sloughing, and necrosis if extravasation occurs (the most feared complication)
- Cardiac arrhythmias: bradycardia, ventricular arrhythmias, cardiac arrest, especially with rapid administration
- Hypercalcemia: particularly with repeated doses or in patients with renal insufficiency
- Digitalis toxicity potentiation: calcium enhances digitalis effects and can precipitate fatal arrhythmias
Cardiovascular effects
- Hypotension or hypertension
- Peripheral vasodilation with rapid injection
- Coronary or cerebral vasospasm
- Shortened QT interval
Local reactions
- Burning sensation at injection site
- Venous irritation and thrombophlebitis
- Pain along the vein during infusion
Metabolic disturbances
- Hypercalcemia symptoms: nausea, vomiting, constipation, confusion, lethargy
- Nephrocalcinosis with chronic use
- Milk-alkali syndrome (rare)
Gastrointestinal
- Nausea and vomiting
- Chalky taste
- Abdominal pain
Administration precautions: Calcium chloride should be given slowly (not exceeding 1 mL/min of 10% solution except in cardiac arrest) through a central line when possible. Continuous cardiac monitoring is mandatory during administration.
Contraindications and warnings
Absolute contraindications
- Hypercalcemia or hypercalcemic conditions
- Ventricular fibrillation during cardiac resuscitation (controversial; some guidelines still recommend use)
- Concurrent IV ceftriaxone administration in neonates (risk of fatal precipitation)
Relative contraindications and warnings
- Digitalis therapy: extreme caution required as calcium increases digitalis sensitivity and may precipitate life-threatening arrhythmias; some experts consider this a near-absolute contraindication
- Renal insufficiency: increased risk of hypercalcemia and calcium deposition
- Respiratory acidosis or failure: may worsen acidosis
- Cardiac disease: increased arrhythmia risk, particularly in acute myocardial infarction
Special populations
Pregnancy: Generally considered safe when indicated for acute maternal conditions; calcium crosses the placenta. Risk category not formally assigned under current labeling.
Renal impairment: Dose reduction and careful monitoring required; increased risk of hypercalcemia and soft tissue calcification.
Elderly patients: More susceptible to adverse effects; may have underlying renal impairment or be on digitalis therapy.
Administration warnings
- Never give intramuscularly, subcutaneously, or via peripheral IV if avoidable
- Do not mix with bicarbonate, phosphates, sulfates, or carbonates (precipitation occurs)
- Avoid rapid injection except in cardiac arrest
- Extravasation can cause severe necrosis requiring surgical debridement
- Ensure IV line patency before and during administration
Drug interactions
Major interactions
Cardiac glycosides (digoxin, digitoxin): Calcium potentiates digitalis effects on the heart, markedly increasing the risk of cardiac arrhythmias including ventricular fibrillation. This combination should be avoided or used only with extreme caution and continuous cardiac monitoring.
Ceftriaxone: Concurrent IV administration can result in precipitation of calcium-ceftriaxone salts in lungs and kidneys, potentially fatal in neonates (≤28 days old). In neonates, do not administer within 48 hours of each other. In older patients, sequential administration is acceptable if the infusion line is thoroughly flushed between infusions.
Thiazide diuretics: Reduce renal calcium excretion, increasing hypercalcemia risk with chronic calcium supplementation.
Moderate interactions
Calcium channel blockers: Calcium chloride antagonizes the therapeutic effects and is used intentionally to treat toxicity, but may reduce efficacy in therapeutic use.
Sodium phosphate: Concurrent administration may result in calcium phosphate precipitation.
Tetracyclines and fluoroquinolones: Oral calcium reduces absorption of these antibiotics (not relevant for IV calcium chloride in acute settings).
Levothyroxine: Calcium can reduce absorption of oral thyroid hormones.
Other considerations
Bicarbonate and carbonate salts: Precipitation occurs; incompatible for mixing in IV solutions.
Phosphate: Calcium and phosphate can precipitate; monitor both electrolytes and avoid simultaneous rapid infusion.
Catecholamines: Calcium may enhance vasopressor effects.
Neuromuscular blocking agents: Calcium reverses the effects of non-depolarizing agents and may enhance depolarizing blockade.
Clinical pearls
Calcium chloride vs calcium gluconate
Calcium chloride provides three times more elemental calcium per gram than calcium gluconate (27% vs 9%). In cardiac arrest, severe symptomatic hypocalcemia, and calcium channel blocker toxicity, calcium chloride is preferred. Calcium gluconate is safer for peripheral IV access due to lower tissue damage risk with extravasation.
Exam-relevant facts
- Calcium chloride dissociates directly in the blood and does not require hepatic metabolism for activation
- Always consider digitalis toxicity before giving calcium; the combination can be lethal
- Calcium treats the cardiac effects of hyperkalemia without lowering potassium levels (it stabilizes membranes; insulin/glucose or dialysis is needed to actually reduce K⁺)
- In massive transfusion, citrate (anticoagulant in blood products) chelates calcium, causing hypocalcemia
Administration tips
- Central line preferred: Give via central venous catheter when possible to minimize extravasation risk
- Confirm line patency: Flush before and after; aspirate to verify position
- Slow push: 1 mL/min maximum rate except during cardiac arrest
- Monitor continuously: ECG monitoring is mandatory; watch for bradycardia or shortened QT
- If extravasation occurs: stop immediately, aspirate residual drug, apply warm compresses, consider hyaluronidase injection
High-yield testing associations
- Chvostek and Trousseau signs: Indicate severe hypocalcemia requiring urgent calcium replacement
- Prolonged QT interval: ECG finding in hypocalcemia that may lead to torsades de pointes
- Hydrofluoric acid burns: Calcium chloride (IV and topical calcium gluconate gel) is specific treatment
- Citrate toxicity: Think of this in massive transfusion protocols; ionized calcium drops precipitously
Calcium Chloride = C for CENTRAL line (to remember it should be given centrally to avoid tissue necrosis, unlike gluconate which is safer peripherally)
Practice questions
1. A 62-year-old man is brought to the emergency department after ingesting an overdose of amlodipine 4 hours ago. He is hypotensive (BP 75/40 mmHg), bradycardic (HR 42/min), and lethargic. IV fluids and atropine have been given without significant improvement. ECG shows sinus bradycardia with first-degree AV block. Which of the following is the most appropriate next step in management?
2. A 45-year-old woman with end-stage renal disease on hemodialysis presents with muscle cramps, perioral tingling, and carpopedal spasm. Serum calcium is 6.2 mg/dL (normal 8.5-10.5). ECG shows prolonged QT interval. The physician orders IV calcium replacement. Which of the following is a contraindication to administering calcium chloride to this patient?
3. A 28-year-old man is receiving his 10th unit of packed red blood cells following a motor vehicle collision with massive hemorrhage. He suddenly develops hypotension and perioral numbness. ECG shows prolonged QT interval. Ionized calcium level is 0.85 mmol/L (normal 1.15-1.35). Which of the following best explains this patient's hypocalcemia?
Frequently asked questions
How does calcium chloride work?
Calcium chloride rapidly increases serum ionized calcium levels by dissociating into calcium ions (Ca²⁺). These ions stabilize cardiac cell membranes by raising the threshold potential, enhance myocardial contractility, and antagonize the cardiac effects of hyperkalemia without lowering potassium levels. In calcium channel blocker toxicity, it overcomes competitive receptor blockade at L-type calcium channels.
What are the side effects of calcium chloride?
The most serious side effect is severe tissue necrosis if the drug extravasates from the vein. Rapid administration can cause cardiac arrhythmias including bradycardia and ventricular arrhythmias, especially in patients taking digitalis. Other effects include hypercalcemia with repeated doses, hypotension or hypertension, venous irritation, and a burning sensation at the injection site. It should always be given slowly with cardiac monitoring.
What is the difference between calcium chloride and calcium gluconate?
Calcium chloride contains 27% elemental calcium while calcium gluconate contains only 9%, providing three times more calcium per gram. Both dissociate directly in the blood to release ionized calcium. Calcium chloride is preferred in cardiac arrest and severe emergencies due to its higher calcium content. However, calcium chloride causes much more severe tissue damage if it leaks from the vein (extravasation), so it requires central line administration when possible. Calcium gluconate is safer for peripheral IV use.
When is calcium chloride used in cardiac arrest?
Calcium chloride is used in cardiac arrest when there is suspected or confirmed hyperkalemia, hypocalcemia, calcium channel blocker toxicity, or magnesium toxicity. It is not routinely given in all cardiac arrests. The calcium rapidly stabilizes cardiac membranes and improves contractility. However, it should not be mixed with sodium bicarbonate in the same IV line as precipitation will occur.
Why can't you give calcium chloride with digoxin?
Calcium potentiates the effects of cardiac glycosides like digoxin on the heart, dramatically increasing the risk of life-threatening arrhythmias including ventricular fibrillation. Both calcium and digoxin increase intracellular calcium in cardiac myocytes, and their combined effect can trigger fatal dysrhythmias. If calcium must be given to a patient on digoxin, it should be administered very slowly with continuous cardiac monitoring, or avoided entirely if possible.
Conditions it is used for
Related drugs
Sources and further reading
DailyMed (FDA labels)StatPearls (NCBI Bookshelf)MedlinePlusWHO ATC/DDD index: A12AA07WHO ATC/DDD index: B05XA07
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.